EYPT (EYPT) Stock Price & Analysis
EYPT (EYPT) rose 0.33% to USD 4.58 as of September 8, 2026 at 07:36 UTC, according to Nexqual real-time market data.
EYPT last closed at USD 4.58; the session ranged USD 4.49–4.69 on volume of 1,901,886 shares. Market capitalization is —, with a 52-week range of USD 3.95–19.11 (NGM). Source: Nexqual, September 8, 2026 at 07:36 UTC.
Key Statistics (as of September 8, 2026 at 07:36 UTC)
| Price | USD 4.58 |
|---|---|
| Change | ▲ 0.33% (up) |
| Previous Close | USD 4.58 |
| Open | USD 4.58 |
| Day Range | USD 4.49 – 4.69 |
| 52-Week Range | USD 3.95 – 19.11 |
| Volume | 1,901,886 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (EYPT)
Nexqual's technical model rates EYPT "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:36 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.46 (oversold) |
| vs SMA50 | Below (USD 10.78) |
| MACD | -2.01 (negative) |
From EYPT's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc. | USD 10.64 | ▼ 2.39% |
| FULC | Fulcrum Therapeutics, Inc. | USD 3.85 | ▲ 0% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.97 | ▲ 0.2% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| SLDB | Solid Biosciences Inc. | USD 10.25 | ▼ 0.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:36 UTC. This page is informational and not investment advice.